Is Kybella the Next Big Thing? One Surgeon Shares His Insights and Experience with Kybella
Joe Niamtu III, DMD, shares his insights and experience with Kythera Biopharmaceuticals’ new fat-dissolving injectable Kybella in this August 2015 feature.
Joe Niamtu III, DMD, shares his insights and experience with Kythera Biopharmaceuticals’ new fat-dissolving injectable Kybella in this August 2015 feature.
Allergan has revamped its Brilliant Distinctions program so patients earn points on non-Allergan services. Aerolase, Merz, and Synergy also offer loyalty programs to grow your practice.
Where in the world is Wendy Lewis? At the 17th Annual International Master Course on Aging Skin (IMCAS), of course.
Allergan Plc is rolling out its first advertising campaign that directly pitches its blockbuster wrinkle-smoothing treatment Botox to men. The campaign will include TV commercials.
Read MoreApproved in April 2015, Kybella (deoxycholic acid, Allergan) generated a lot of buzz as an injectable treatment to rid adults of their double chins. So what are physicians saying about Kybella three years later?
Read MoreIn the December 2015 PSP Editor’s Note, Denise Mann shares an update on the pursuit of Allergan–which she notes was the biggest story of 2015.
Read MoreJUVEDERM ULTRA XC for lips and Coolscupting’s new Coolmini for the double chin are among November’s “Hot Stuff.”
Read MoreThe FD gave its nod to Allergan’s NATRELLE INSPIRA™ round gel-filled smooth breast implants for women undergoing breast reconstruction, augmentation, or revision surgery.
Read MorePSP Editor Denise Mann shares insights from her interview with David Pyott, chairman and CEO of Allergan, and Brent Saunders, CEO of Actavis.
Read MoreThey say making predictions is a fool’s errand, but that doesn’t stop PSP editor Denise Mann from taking a stab at it.
Read MoreThe FDA and Health Canada have given their nod to the IDEAL IMPLANT®, clearing it for marketing
Read MoreThe US Food and Drug Administration has given its nod to two new styles of Allergan’s Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants for use in breast reconstruction, augmentation, and revision surgery.
Read MoreNearly 60% of women aged 21-65 say they’d rather have a more youthful looking face than body, according to a survey conducted on behalf of Allergan, Inc.
Read MoreDownload Made to Match: Guide to the Natrelle® 410 Two-Stage Beast Reconstruction System today.
Read MoreBayer has agreed to acquire Merck & Co’s consumer care business for $14.2 billion, according to media reports.
Read MoreBayer has agreed to acquire Merck & Co’s consumer care business for $14.2 billion, according to media reports.
Read More